Clinical Trial Update: Tolcapone in Obsessive Compulsive Disorder [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial update for tolcapone in obsessive-compulsive disorder has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Tolcapone (tolcapone)

Snippet

Sponsor: University of Chicago | Conditions: Obsessive-Compulsive Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-04-07